Pitterle ME - Search Results

1

Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy.

Gidal BE, DeCerce J, Bockbrader HN, Gonzalez J, Kruger S, Pitterle ME, Rutecki P, Ramsay RE. Gidal BE, et al. Among authors: pitterle me. Epilepsy Res. 1998 Jul;31(2):91-9. doi: 10.1016/s0920-1211(98)00020-5. Epilepsy Res. 1998. PMID: 9714500 Free article. Clinical Trial.

2

Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.

Gidal BE, Pitterle ME, Spencer NW, Maly MM. Gidal BE, et al. Among authors: pitterle me. J Clin Pharm Ther. 1995 Aug;20(4):215-9. doi: 10.1111/j.1365-2710.1995.tb00651.x. J Clin Pharm Ther. 1995. PMID: 8557785 Clinical Trial.

3

Effect of a high-protein meal on gabapentin pharmacokinetics.

Gidal BE, Maly MM, Budde J, Lensmeyer GL, Pitterle ME, Jones JC. Gidal BE, et al. Among authors: pitterle me. Epilepsy Res. 1996 Feb;23(1):71-6. doi: 10.1016/0920-1211(95)00051-8. Epilepsy Res. 1996. PMID: 8925804 Clinical Trial.

4

Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.

Gidal BE, Rutecki P, Shaw R, Maly MM, Collins DM, Pitterle ME. Gidal BE, et al. Among authors: pitterle me. Epilepsy Res. 1997 Oct;28(3):207-11. doi: 10.1016/s0920-1211(97)00053-3. Epilepsy Res. 1997. PMID: 9332885

5

Gabapentin absorption: effect of mixing with foods of varying macronutrient composition.

Gidal BE, Maly MM, Kowalski JW, Rutecki PA, Pitterle ME, Cook DE. Gidal BE, et al. Among authors: pitterle me. Ann Pharmacother. 1998 Apr;32(4):405-9. doi: 10.1345/aph.17281. Ann Pharmacother. 1998. PMID: 9562133 Clinical Trial.

6

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability.

Gidal BE, Radulovic LL, Kruger S, Rutecki P, Pitterle M, Bockbrader HN. Gidal BE, et al. Epilepsy Res. 2000 Jul;40(2-3):123-7. doi: 10.1016/s0920-1211(00)00117-0. Epilepsy Res. 2000. PMID: 10863139 Clinical Trial.

7

Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.

Gidal BE, Spencer NW, Maly MM, Pitterle ME. Gidal BE, et al. Among authors: pitterle me. Epilepsia. 1996 Apr;37(4):381-5. doi: 10.1111/j.1528-1157.1996.tb00576.x. Epilepsia. 1996. PMID: 8603645

8

Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.

Gidal BE, Inglese CM, Meyer JF, Pitterle ME, Antonopolous J, Rust RS. Gidal BE, et al. Among authors: pitterle me. Pediatr Neurol. 1997 May;16(4):301-5. doi: 10.1016/s0887-8994(97)00026-x. Pediatr Neurol. 1997. PMID: 9258962

9

Potential interaction between carbamazepine and loxapine: case report and retrospective review.

Collins DM, Gidal BE, Pitterle ME. Collins DM, et al. Among authors: pitterle me. Ann Pharmacother. 1993 Oct;27(10):1180-7. doi: 10.1177/106002809302701003. Ann Pharmacother. 1993. PMID: 8251682 Review.

10

Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.

Gidal B, Spencer N, Maly M, Pitterle M, Williams E, Collins M, Jones J. Gidal B, et al. Neurology. 1994 Aug;44(8):1418-22. doi: 10.1212/wnl.44.8.1418. Neurology. 1994. PMID: 8058141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page